Status:

COMPLETED

Lumbar Plexus Block Versus Quadratus Lumborum Block for Primary Anterior Total Hip Arthroplasty

Lead Sponsor:

Wake Forest University Health Sciences

Conditions:

Osteoarthritis

Total Hip Arthroplasty

Eligibility:

All Genders

18-95 years

Phase:

NA

Brief Summary

Total hip arthroplasty (THA) is one of the most successful orthopedic procedures to effectively relieve pain and restore function in patients with end stage osteoarthritis. In an attempt to accelerate...

Detailed Description

In an attempt to accelerate recovery many orthopedic surgeons have opted to utilize a direct anterior approach (DAA) as opposed to the more traditional posterolateral approach (PLA) in regards to tota...

Eligibility Criteria

Inclusion

  • Any patient between the ages of 18 and 95 years undergoing a primary elective, unilateral DAA total hip arthroplasty.

Exclusion

  • If the patient uses more than 40mg of Oxycodone equivalents per 24 hours or is on extended release opioid formulations.
  • Indication for surgery is secondary to trauma and/or hip fracture
  • If there is a contraindication to the performance of a regional block
  • Concomitant anticoagulation use or documented coagulopathy
  • Infectious or dermatologic conditions in the area of block placement that would otherwise increase the risk of peripheral nerve blockade
  • Presence of progressive neurologic deficit effecting peripheral nerves
  • Allergy or adverse reaction to study drugs to include: fentanyl, epinephrine, and amide local anesthetics
  • American Society of Anesthesia Physical Classification score \> or = to 4
  • Allergies to study drugs other than local anesthetic
  • BMI \> 40
  • Patient refusal
  • Pregnancy
  • Institutionalized individuals
  • Extremes of age: Age \> 95 or \< 18
  • Non English speaking or inability to reliably participate in the study

Key Trial Info

Start Date :

March 4 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 22 2019

Estimated Enrollment :

44 Patients enrolled

Trial Details

Trial ID

NCT03409900

Start Date

March 4 2019

End Date

November 22 2019

Last Update

May 12 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Wake Forest Baptist Medical Center

Winston-Salem, North Carolina, United States, 27157